A detailed history of Wedbush Securities Inc transactions in Novavax Inc stock. As of the latest transaction made, Wedbush Securities Inc holds 10,997 shares of NVAX stock, worth $101,502. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,997
Previous 22,826 51.82%
Holding current value
$101,502
Previous $289,000 51.9%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$10.71 - $17.11 $126,688 - $202,394
-11,829 Reduced 51.82%
10,997 $139,000
Q2 2024

Aug 06, 2024

BUY
$3.89 - $20.97 $43,836 - $236,310
11,269 Added 97.51%
22,826 $289,000
Q4 2023

Feb 12, 2024

SELL
$4.8 - $7.67 $1,200 - $1,917
-250 Reduced 2.12%
11,557 $55,000
Q3 2023

Nov 14, 2023

BUY
$6.81 - $9.74 $10,215 - $14,610
1,500 Added 14.55%
11,807 $85,000
Q1 2023

May 09, 2023

SELL
$5.76 - $12.48 $7,228 - $15,662
-1,255 Reduced 10.85%
10,307 $71,000
Q4 2022

Jan 31, 2023

BUY
$8.86 - $25.04 $2,480 - $7,011
280 Added 2.48%
11,562 $119,000
Q3 2022

Oct 18, 2022

BUY
$18.2 - $76.12 $5,915 - $24,739
325 Added 2.97%
11,282 $205,000
Q2 2022

Jul 21, 2022

BUY
$36.28 - $75.29 $70,383 - $146,062
1,940 Added 21.51%
10,957 $563,000
Q1 2022

Apr 19, 2022

BUY
$69.73 - $142.9 $256,676 - $526,014
3,681 Added 68.98%
9,017 $664,000
Q4 2021

Jan 13, 2022

BUY
$134.56 - $217.97 $130,119 - $210,776
967 Added 22.13%
5,336 $763,000
Q3 2021

Oct 08, 2021

BUY
$177.8 - $270.58 $114,681 - $174,524
645 Added 17.32%
4,369 $905,000
Q2 2021

Jul 27, 2021

BUY
$121.0 - $257.67 $12,100 - $25,767
100 Added 2.76%
3,724 $790,000
Q1 2021

Apr 26, 2021

SELL
$112.98 - $319.93 $83,718 - $237,068
-741 Reduced 16.98%
3,624 $657,000
Q4 2020

Feb 16, 2021

BUY
$78.74 - $139.5 $68,976 - $122,202
876 Added 25.11%
4,365 $487,000
Q3 2020

Oct 20, 2020

SELL
$79.44 - $178.51 $95,566 - $214,747
-1,203 Reduced 25.64%
3,489 $378,000
Q2 2020

Jul 16, 2020

BUY
$13.86 - $83.61 $65,031 - $392,298
4,692 New
4,692 $391,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $722M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.